Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
-0.1%/yr
vs +1.2%/yr prior
5Y CAGR
-0.0%/yr
Consistent
Acceleration
-1.3pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | 87.91% | -2.3% |
| 2024 | 89.98% | -0.7% |
| 2023 | 90.65% | +2.7% |
| 2022 | 88.28% | -0.5% |
| 2021 | 88.72% | +0.7% |
| 2020 | 88.10% | +0.2% |
| 2019 | 87.95% | +4.4% |
| 2018 | 84.21% | +1.3% |
| 2017 | 83.11% | -0.1% |
| 2016 | 83.20% | - |